In this enlightening episode, Ryan engages in a deep conversation with Dr. Paul Hutson, PharmD, a renowned researcher in the field of psilocybin and director of the Transdisciplinary Center for Research in Psychoactive Substances at the University of Wisconsin Madison. Dr. Hutson shares his extensive knowledge and insights into the promising role of psilocybin in the treatment of depression and substance use disorder.  

Throughout the discussion, they delve into the research that supports the use of psilocybin in medical therapy, shedding light on the rigorous processes involved in conducting such studies. Dr. Hutson elucidates the efficacy and safety findings that have emerged from his and others research, offering listeners a glimpse into the potential future of psilocybin in mainstream medical practices. Listeners will gain a deeper understanding of the meticulous approach to research that ensures both safety and effectiveness. Dr. Hutson shares firsthand experiences and observations, providing a rich and detailed perspective on the current state of psilocybin research. Moreover, the conversation ventures into the practical aspects of integrating psilocybin into contemporary medical practices, discussing the potential frameworks and guidelines that would govern its use. They explore what the future might hold for patients and practitioners alike as they stand on the cusp of a revolutionary shift in mental health treatment.

Whether you're a healthcare professional keen on the latest developments in medical research or someone interested in the evolving landscape of mental health treatment, this episode promises to be a rich source of information and insight. Tune in to be informed and to foster a deeper understanding of the promising horizon that psilocybin research is unveiling in the medical community.

• Biography for Dr. Paul Hutson PharmD
• Transdisciplinary Center for Research in Psychoactive Substances
• Dr Hutson's Publications
  • Single Dose Psilocybin for Major Depression- JAMA 2023
  • Psilocybin and QTc in healthy volunteers
  • Meta-Analysis of research supporting Psilocybin use in anxiety and depression
  • Pharmacokinetics of Psilocybin
  • Subjective effects of high dose Psilocybin
  
  
• Other referenced studies
  • Single dose psilocybin for treatment resistant depression 
  • Psilocybin for alcohol use disorder
  • Psilocybin for For tobacco cessation
  
  

• Sign up for the newsletter!
• Support the show!
• Rep the show!
• Show website